These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26884217)

  • 1. [Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis].
    Funke-Chambour M; Geiser T
    Ther Umsch; 2016; 73(1):25-9. PubMed ID: 26884217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Idiopathic Pulmonary Fibrosis].
    Prasse A
    Pneumologie; 2015 Oct; 69(10):608-14; quiz 615. PubMed ID: 26444136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing Idiopathic Pulmonary Fibrosis: Which Drug for Which Patient?
    Hayton C; Chaudhuri N
    Drugs Aging; 2017 Sep; 34(9):647-653. PubMed ID: 28861727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of new drug treatments for idiopathic pulmonary fibrosis.
    Fletcher S; Jones MG; Spinks K; Sgalla G; Marshall BG; Limbrey R; Richeldi L
    Expert Opin Drug Saf; 2016 Nov; 15(11):1483-1489. PubMed ID: 27532218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MODERN APPROACH TO THERAPY OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS].
    Tsvetkova OA; Voronkova OO; Buyanova OE
    Klin Med (Mosk); 2017; 95(3):281-5. PubMed ID: 30303652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antifibrotic treatment].
    von der Beck D; Löh B; Drakopanagiotakis F; Markart P; Günther A
    Dtsch Med Wochenschr; 2014 Dec; 139(49):2523-5. PubMed ID: 25423462
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.
    Loeh B; Drakopanagiotakis F; Bandelli GP; von der Beck D; Tello S; Cordani E; Rizza E; Barrocu L; Markart P; Seeger W; Guenther A; Albera C
    Am J Respir Crit Care Med; 2015 Jan; 191(1):110-3. PubMed ID: 25551350
    [No Abstract]   [Full Text] [Related]  

  • 8. Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis.
    Sathiyamoorthy G; Sehgal S; Ashton RW
    South Med J; 2017 Jun; 110(6):393-398. PubMed ID: 28575896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis.
    Ogura T; Taniguchi H; Azuma A; Inoue Y; Kondoh Y; Hasegawa Y; Bando M; Abe S; Mochizuki Y; Chida K; Klüglich M; Fujimoto T; Okazaki K; Tadayasu Y; Sakamoto W; Sugiyama Y
    Eur Respir J; 2015 May; 45(5):1382-92. PubMed ID: 25504994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.
    van Manen MJG; Birring SS; Vancheri C; Vindigni V; Renzoni E; Russell AM; Wapenaar M; Cottin V; Wijsenbeek MS
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program.
    Richeldi L; du Bois RM
    Expert Rev Respir Med; 2011 Aug; 5(4):473-81. PubMed ID: 21859266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real world experiences: pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis.
    Chaudhuri N; Duck A; Frank R; Holme J; Leonard C
    Respir Med; 2014 Jan; 108(1):224-6. PubMed ID: 24269005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough.
    Thabut G; Crestani B; Porcher R; Richeldi L
    Eur Respir J; 2015 Sep; 46(3):607-14. PubMed ID: 26324692
    [No Abstract]   [Full Text] [Related]  

  • 14. Pirfenidone in idiopathic pulmonary fibrosis.
    Swigris J; Fairclough D
    Eur Respir J; 2010 Sep; 36(3):695-6; author reply 696-8. PubMed ID: 20930209
    [No Abstract]   [Full Text] [Related]  

  • 15. An updated safety review of the drug treatments for idiopathic pulmonary fibrosis.
    Sgalla G; Comes A; Richeldi L
    Expert Opin Drug Saf; 2021 Sep; 20(9):1035-1048. PubMed ID: 33881959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pirfenidone for idiopathic pulmonary fibrosis.
    Bouros D
    Lancet; 2011 May; 377(9779):1727-9. PubMed ID: 21571363
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential.
    Raghu G
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
    Poletti V; Ravaglia C; Tomassetti S
    Expert Rev Respir Med; 2014 Oct; 8(5):539-45. PubMed ID: 25113033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation.
    Maher TM; Lancaster LH; Jouneau S; Morrison L; Lederer DJ; Molina-Molina M; Bendstrup E; Kirchgaessler KU; Gilberg F; Axmann J; Petzinger U; Noble PW
    Ann Am Thorac Soc; 2019 Jul; 16(7):927-930. PubMed ID: 30950636
    [No Abstract]   [Full Text] [Related]  

  • 20. Current approaches to the management of idiopathic pulmonary fibrosis.
    Raghu G; Richeldi L
    Respir Med; 2017 Aug; 129():24-30. PubMed ID: 28732832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.